chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The muscle pain dissapated after a few days but recurred a week later along with an approximately 2 1/2 by 3 iinch area of redness, warmth and slight hardening surrounding the vaccination site.  This area later began to itch.  It is still a little warmer than the other upper arm and itchy and slightly tender but not as hard or red as it was previously.
This spontaneous report as received from a pharmacist refers to multiple patients of unknown age and gender. On an unknown date, the patients were vaccinated with doses of improperly stored PNEUMOVAX 23 lot # K021030, expiration date: 22-JUN-2016. No adverse effects were reported. Additional information has been requested.
chest pain, arm pain (back of arms, biceps), rapid heart rate, shortness of breath, chest pressure.
Lack of drug effect; Positive Covid after vaccine; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive Covid after vaccine) and DRUG INEFFECTIVE (Lack of drug effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Positive Covid after vaccine) and DRUG INEFFECTIVE (Lack of drug effect). At the time of the report, COVID-19 (Positive Covid after vaccine) and DRUG INEFFECTIVE (Lack of drug effect) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19 screening: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided  No Treatment medications were provided   Reporter did not allow further contact
Client is a 57-year-old male with a history of experiencing dizziness when given an injection. Client was vaccinated with 0.5 ml of Janssen vaccine. At 10:57 am the client stated that he began to feel dizzy. The client was assisted from the chair to a cot, and assisted into a supine position with both legs elevated. The client denied any other symptoms.  A set of vital signs were taken at 10:58; Blood pressure 134/78, pulse: 72 and strength was +3; 02 sat 98%; RR: 16; Anterior lung sounds were clear bilaterally.  Pt was instructed to lay down until he feels well enough to sit up. The client was instructed to change positions slowly from lying to sitting, then sitting to standing. Pt was advised to stay under observation for 30 minutes . At 11:10 am, the client was able to sit down in a chair in the observation tent and have a drink of water. At 11:30 vital signs were reassessed. Vital signs were blood pressure  122/76, Pulse 64, 02 sat: 98% and client reported feeling fine, and thanked the staff for their help. The client then walked out of the event.
Initial and follow up information has been received from a nurse practitioner, for VARIVAX (Merck), a Pregnancy Registry product, concerning a 17 year old female patient with no pertinent medical history or drug/allergies reported, and no previous pregnancies, who on 19-OCT-2010 was vaccinated with a dose of VARIVAX (Merck) (Lot # 667317/0638Z), 0.5 mL, SC. There was no concomitant medication. It was reported that the patient received a dose of VARIVAX (Merck) while she was pregnant. Her last menstrual period was on 12-SEP-2010 and her date of delivery was 19-JUN-2011. Pregnancy was confirmed by pregnancy test. The patient was not tested for varicella antibodies before vaccination with VARIVAX (Merck). No adverse event symptoms were observed or reported by the patient. Follow up information was received via telephone call from a reporter located in the health care center where the patient was seen for prenatal care, who stated that on 27-SEP-2010, the patient underwent an elective abortion to end her pregnancy. The reporter stated that the fetus was viable and pregnancy had no problems; it was the patient's choice to terminate her pregnancy. Upon internal review, elective abortion was determined to be an other important medical event. No further information is available.
expired dose was given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose was given after expiration date) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose was given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired dose was given after expiration date) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment information was provided.  No adverse event was reported. The vial had not undergone any temperature excursion issue. The vial was initially placed in the refrigerator on 01-Mar-2022. Many doses were administered from expired lots due to confusion with the expiration date printed in the carton.
Received Pfizer vaccines on  2/25, 3/18, 12/8/21 COVID-19 positive by PCR on  12/12/21. Hospitalized 12/12-12/26/21 d/t COVID 19 pneumonia readmitted on 1/10/22 d/t respiratory distress in setting of COVID 19. underlying COPD, HTN, h/o stroke, pulmonary fibrosis, AAA
Redness, prickly/itching sensation over face, arms, legs, chest/abdomen, burning sensation on lips and around eyes, pressure/fullness in back of throat, pain in infections site, fatigue, muscle aches.
Pt. received vaccine at 10:59 1/29/11. On 1/31/11 she came to pharmacy to inquire transmission to grandson. She did not have any reac at inj. site at that time. On 2/1/11 she came to show me the inj site - reddened with small purple center. Area is warm to touch & slightly hardened. Advised her to not let grandson touch area & to see MD if it does not improve.
Chest pain on left side:  - daily occurrence  - doesn't last long, but occurs regularly and frequently throughout the day  Noticeable increase in difficulty hearing and understanding people.  Noticeable decrease in vision. Blurred vision.   Noticeable increase in headaches and tension across the entire skull.
Patient experienced increased BP and pulse. Diaphoresis along with muscle spasming. Sent to ER - given IVF. Symptoms completely resolved today. Staff has entered exception.
Patient experienced syncope after receiving the vaccine. I was able to help the patient up and brought him water and a snack. Patient reported he had not eaten yet today. After monitoring him for 15 minutes he felt he was able to stand again and had his father pick him up.
Monday, January 4 in the evening I became very fatigued, to the point where I couldn't stay awake.  When I woke up a few hours later, I noticed that I had a very bad headache and all-over body aches, and I felt like I had the flu.  Weak, nauseous and extremely tired.  I went to bed and slept through the night, when my alarm woke me at 7:00 am on Tuesday, January 5, I got up to use the bathroom and felt all the same symptoms from the night before, only worse.  I noticed that I had a rash on my left arm below the injection site.  I called in sick and went back to bed.  I slept from approximately 7:30 to 2:00 pm on January 5.  I felt a little better upon awakening, but had a very bad headache and no appetite.  The other body aches seemed better.
There was no event but pt did receive Moderna as her first shot on March 18th and Pfizer as her second dose on April 28th. Pt had no problem with the vaccine.
knot noted on rt leg 3AUG96 which was increasing in size;temp was 101-102;5AUG96 temp 103 otic;knot on leg was size of golf ball;pt taken to MD;leg was lanced & drained;drain was put in & bandaged;dressing is changed daily;cult of drainage
He has had a bloody nose for three days; Initial information received on 30-Aug-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 6 years old male patient who experienced bloody nose for three days (epistaxis), while he received vaccine IPV (VERO) [IPOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing cerebral cyst.   On an unknown date, the patient received a dose of suspect IPV (VERO) lot number not reported via unknown route in unknown administration site.  On an unknown date, the patient had a bloody nose for three days (epistaxis) (Unknown latency) following the administration of IPV (VERO).  Final diagnosis was epistaxis.   It was not reported if the patient received a corrective treatment.  The patient outcome was reported as unknown for epistaxis.  List of document held by sender: none.
The provider spoke with MOC  about the vaccine and gave mother all vaccine information and what she need to look out for. A few days after the incident provider called mother again to follow up on patient and mother stated patient is doing good. No reaction to vaccine.
Ptn states pain in left arm. Pain disappeared however now large red/purple (itchy) raised area at injection site and spreading. Advised to seek medical attention.
difficulty breathing and feeling like "throat is closing" within minutes after being vaccinated. Medics started IV, administered 50mg Benadryl via IV, and transported to ER for further evaluation.
I have developed acute anemia, colitis, kidney problems, am to see heart specialist in Oct. and and internal specialist in Oct. Have had bowel specimens done which found the colitis. Low sodium. Still in process of seeing multiple doctors. Saw kidney specialist today. Everything started happening in April sometime. Not  sure exactly when because have been busy with 100% disable husband. Wasn't paying much attention to me, just noticed all these symptoms coming on.
The day that she received her vaccine, she had a dime-sized red raised area, but denies any other complaints. Last night, (12 days after vaccine)  EE noticed the area where she received her vaccine had a large raised red, warm, itchy, and "hard" circular area.  She outlined the area last night, and today, the area of redness is 1-2cm outside of the outline. Left arm rash, deltoid area, 7.5-8cm, warm, red, firm.
Sligth temperature; Achy; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Sligth temperature) and PAIN (Achy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced PYREXIA (Sligth temperature) and PAIN (Achy). At the time of the report, PYREXIA (Sligth temperature) and PAIN (Achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Information has been received from a registered nurse concerning an 8 year old white male with no known allergies who on 01-OCT-1999 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). There was no illness at the time of vaccination. On 17-MAR-2007 the patient experienced rash. On 19-MAR-2007, the patient was seen in the office with 50 small papules/pustules on trunk, face, and limbs. It was reported that the patient's grandfather has shingles 2 weeks prior while taking care of the patient. The patient recovered on 24-MAR-2007. No further information is available.
24hr p/vax pt devel erythema & warmness @ inj site, tightness in chest, swollen lymph glands in neck, fever;pt hosp tx w/solumedrol & nafcillin; Annual follow-up received on 10/04/00 states the pt has recovered.
Pt complained of headache, light sensitivity, neck stiffness, body aches, nausea and fever starting on 4Feb.  Pt was given 1GM Rocephin, Zofran and Tylenol.
Patient reported her arm being in pain when she tries to lift her arm. Patient went to see PCP and they said the vaccine was given in correct location but she had developed a tendonitis. Patient is taking ibuprofen as needed which helps and is going to physical therapy. The patient states now she is  getting better with physical therapy.
patient and her husband came into pharmacy for their 1st dose of moderna covid19 vaccine. they expressed that they're very anxious and nervous about getting the vaccine and waited this far to get it.  I gave the patient the shot at 12:40pm and right after the shot she excitedly stated "wow, I did not feel anything at all. thank you!". I then told her to join her husband and have a seat at the post-vaccination monitoring area. At 12:51, I checked her on her and husband. Her husband stated that she was happy when she got out of the room but now  it looks like she's very tired and not responding to him when he asked her  some questions. I made a suggestion to give her some water and to have him taking back to our immunization room so it's more private for her to rest. He had to dragged her into the room while I carried her back. He then said please call paramedics because it seems like she's passing out. Our pharmacy staff checked with her husband again to make sure he wanted us to dial 911. At soon as he said yes ! please call 911, she suddenly gained consciousness, opened her eyes and started talking and told us she wants a soda. We tried to check her blood pressure with the automated machine and it read 75/57 twice. We gave her some chips and soda to help. She spent over 1 hour in our room then stated  she felt much better and left with her husband around 2 pm.
Woke with pain in arm and general body aches.  Had mild fever (99.0) around 9:00am followed by chills.  Around 2:45pm, my watch alerted me that my heart rate was high even though I was sitting down over a period of 10 minutes.  Heart rate was between 120 and 125 during this time.  I then took my blood pressure and received a reading of 122/84 with a pulse of 119.  I took my pulse again at 3:00pm and it was still 117-120.
big bruise the size of a 3 inch circle.; severe inflammatory reaction; Initial information received on 07-Feb-2020 regarding an unsolicited valid non-serious case received from a consumer.  This case involves female patient who experienced big bruise the size of a 3 inch circle. and severe inflammatory reaction, while she received vaccine INFLUENZA VACCINE.  medical history included Macular degeneration in FEB-2019. The patient's past medical treatment included LUCENTIS. The patient's past vaccination(s) and family history were not provided.  Concomitant medications included AFLIBERCEPT (EYLEA).  On 02-Oct-2019, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and Expiry date unknown) via unknown route in the arm nos for Prophylactic vaccination.  On an unknown date, the patient developed a non-serious big bruise the size of a 3 inch circle. (contusion) and severe inflammatory reaction (eye inflammation) (Unknown latency) following the administration of INFLUENZA VACCINE.  Final diagnosis was severe inflammatory reaction and big bruise the size of a 3 inch circle..   The patient was treated with PANTOPRAZOLE SODIUM SESQUIHYDRATE (DURAZOL).  The event outcome is reported as Unknown for Bruise and Eye inflammation.  Information on the batch number was requested.
SM presents today for second dose of Pfizer vaccine at 0724 13 mins post injection SM states she began feeling her throat was scratchy, mouth tasted metallic and a flushed felling over her entire body.  SM attached to VS machine.  Initial set of vitals were HR 77 bpm, spo2 100% on RA, and left arm blood pressure 158/84.
Patient woke up to what appeared to be a seizure. She was visibly shaken and had a very high fever. I administered Motrin immediately and took her to my bed to calm her down. She kept having strong full-body twitches for the next 3-4 hours that would scare her when they happened. It has been 12 hours now since then and the twitching has disappeared, but the fever remains. No other respiratory, etc symptoms are visable. Mood has improved and she is happy with occasional fatigue and irritability. Called responsible doctor's office and was told just to monitor at home. Vaccine interaction was never mentioned to me by them, but I decided to contact after reading and verifying symptoms on the vaccine fact sheet.
fever >100-APAP-ER rx & suppositores;mom states pt eyes rolled up, trembling, & purple around mouth, unresponsive;temp taken @ ER 104;mom told pt had a rxn to vax;seen by MD in AM & given medicine for fever; mom states pt is fine 2PM
I tested positive for COVID-19. I had a runny nose and headache. I received a steroid shot and I used Mucinex and Sudafed as treatment.
sickest he's ever been; felt he was "on his deathbed"/had bad reaction; Initial information received on 16-Jun-2020 and additional information recieved on 18-Jun-2020 respectively regarding an unsolicited valid serious case from a consumer/non-health care professional.  This case involves a 73 years old male patient who was sickest ever been (malaise) and had bad reaction, felt he was "on his deathbed" (unevaluable event), while he received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment, past vaccination and family history were not provided. Concomitant medication were not reported.  On an unknown date in 1978, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date in 1978, the patient was sickest ever been (malaise) and had bad reaction, felt he was "on his deathbed" (unevaluable event) (Unknown latency) following the administration of INFLUENZA VACCINE. The patient was hospitalized for these events for multiple days in 1978.  Laboratory details were not reported.  Final diagnosis was malaise and unevaluable event.   It was not reported if the patient received any corrective treatment.  The event outcome was not reported.  Information on batch number was requested.; Sender's Comments: A 73 year old male patient experienced malaise and unevaluable reaction (described as felt like being on deathbed) after vaccination with INFLUENZA VACCINE (unknown manufacturer). The time to onset is unknown. Medical history, concomitant medication and lab data ruling out alternative etiologies would be needed for complete assessment of the case. Based on the reported information role of vaccine cannot be assessed.
Generalized itching started the evening of vaccine. Increased in sensitivity, esp in scalp over next 3 days. Broke out in hives 3 days after vaccine-both arms and face.  Given po Benadryl with improvement.  Hives gone after 2 doses of Benadryl.  Rx for Zyrtec started.
Rash that was present on the injection arm that continued onto her mid back; Headache; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (Rash that was present on the injection arm that continued onto her mid back) and HEADACHE (Headache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced HEADACHE (Headache). On 10-Feb-2021, the patient experienced INJECTION SITE RASH (Rash that was present on the injection arm that continued onto her mid back). At the time of the report, INJECTION SITE RASH (Rash that was present on the injection arm that continued onto her mid back) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Hives, itching rash all over body, swelling, nauseated. Within 2 hours after receiving shot.
No additional AE's and no PQC's were reported.; A pharmacist could not rule out that the pharmacy may administer two doses of VAQTA pediatric formulation to an adult patient; This spontaneous report was received from a pharmacist referring to an adult patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 22-DEC-2022, the patient may be administered 2 doses of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, pediatric formulation (strength, lot #, expiry date, and route of administration were not provided) as directed to prevent hepatits A infection (prophylaxis) (product administered to patient of inappropriate age). No additional adverse events (AEs) were reported.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 13-JUN-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (lot # N025428 exp date 19-JUN-2020) (dose and route not provided). Data digital logger was reported. The vaccine was exposed to a temperature of 47 °F to 77 °F for a time frame of 30 minutes. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports received from the same source.; Sender's Comments: US-009507513-1806USA006387: US-009507513-1806USA006474: US-009507513-1806USA006475: US-009507513-1806USA006476: US-009507513-1806USA006477: US-009507513-1806USA006478:
Within one minute after injection I experienced rapid heart beat while sitting down. This lasted about five minutes and after the chest pains and tightness proceeded. The chest pain and tightness lasted for multiple days and felt as if I could have a heart attack. I am still suffering from chest tightness today however it is less than two days ago.
Information has been received on 09-JUL-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. In 2006, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route, at a physician's office as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 28-MAR-2016, the patient was treated by a physician at a dermatology center for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
Vaccine administered (Hep A) 6/7/2017 this was his second dose- the next morning he developed hives, increased today. Northing else now.